Therefore, conversion of glia to neuron using CasRx -mediated knockdown of Ptbp1 shows a potential therapeutic approach for tackling neurodegenerative diseases and brain damage due to neuronal loss (Zhou et al., 2020). The gene discussed is PTBP1; the disease is neurodegenerative disease.